当前位置： SCI文献检索 > CLINICAL THERAPEUTICS期刊下所有文献 > An Observational Study of Concomitant Use of Emerging Therapies and Denosumab or Zoledronic Acid in Prostate Cancer.

An Observational Study of Concomitant Use of Emerging Therapies and Denosumab or Zoledronic Acid in Prostate Cancer.

Abstract：

PURPOSE:This observational study of oncologic clinical practices was designed to describe real-world patterns of use of emerging therapies (abiraterone acetate, cabazitaxel, enzalutamide, radium-223, sipuleucel-T) in patients with castration-resistant prostate cancer and to characterize their concomitant use with denosumab or zoledronic acid. METHODS:A retrospective cohort study was conducted using a database of electronic health records from oncology practices across the United States. Eligible patients had a diagnosis of prostate cancer (International Classification of Diseases, Ninth Revision [ICD-9] code 185/International Classification of Diseases, Tenth Revision [ICD-10] code C61) before or concurrent with a visit between January 1, 2013, and December 31, 2015; follow-up was performed through June 30, 2016. From this population, we identified those who received an emerging therapy and a subset who also received denosumab or zoledronic acid. FINDINGS:A total of 71,606 men met the eligibility criteria, and 5131 (7%) received emerging therapy. In the emerging therapy cohort (at the time of the first use), median age was 75 years, median prostate-specific antigen value was 22.7 ng/mL, 56% had bone metastases, and 80% were docetaxel naive. Abiraterone and enzalutamide were the most commonly used first emerging therapies (52% and 31%, respectively), followed by sipuleucel-T (9%), cabazitaxel (5%), and radium-223 (1.5%). Of the emerging therapy cohort, 3121 patients (61%) received concomitant denosumab (70%) or zoledronic acid (35%); 5% received both. IMPLICATIONS:Among patients with prostate cancer treated in the United States, most of those treated with an emerging therapy between 2013 and 2015 also received denosumab or zoledronic acid, suggesting that the concomitant use of these therapy types is currently a common practice. Use of denosumab or zoledronic acid was higher in patients with verified bone metastases.

journal_name

Clin Ther

journal_title

Clinical therapeutics

authors

Liede A,Wade S,Lethen J,Hernandez RK,Warner D,Abernethy AP,Finelli A

doi

10.1016/j.clinthera.2017.12.015

subject

Has Abstract

pub_date

2018-04-01 00:00:00

pages

536-549.e3

issue

4

eissn

0149-2918

issn

1879-114X

pii

S0149-2918(17)31121-9

journal_volume

40

pub_type

杂志文章

相关文献

CLINICAL THERAPEUTICS文献大全
  • Differences in Adverse Event Reporting Rates of Therapeutic Failure Between Two Once-daily Extended-release Methylphenidate Medications in Canada: Analysis of Spontaneous Adverse Event Reporting Databases.

    abstract：PURPOSE:Our study evaluated adverse events of therapeutic failure (and specifically reduced duration of action) with the use of a branded product, Osmotic Release Oral System (OROS) methylphenidate, which is approved for the treatment of attention deficit/hyperactivity disorder, and a generic product (methylphenidate, ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2017.08.018

    authors： Park-Wyllie L,van Stralen J,Castillon G,Sherman SE,Almagor D

    更新日期：2017-10-01 00:00:00

  • Differences in adherence to osteoporosis regimens: a 2-year analysis of a population treated under specific guidelines.

    abstract：BACKGROUND:Patients' adherence to antiosteoporotic drug therapy is essential to prevent fracture and complications of osteoporosis over the long term. The guidance given in treating osteoporosis can potentially enhance adherence. OBJECTIVE:This study was conducted to compare adherence to osteoporosis regimens by patie...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2013.05.019

    authors： Cheng TT,Yu SF,Hsu CY,Chen SH,Su BY,Yang TS

    更新日期：2013-07-01 00:00:00

  • Efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD compared with 0.5% levobunolol hydrochloride BID in patients with open-angle glaucoma or ocular hypertension.

    abstract：:We compared the efficacy of timolol maleate ophthalmic gel-forming solution 0.5% QD with that of levobunolol hydrochloride 0.5% BID, as measured by change in intraocular pressure (IOP), effect on heart rate, and ocular tolerability. The study had a positive-controlled, double-masked, randomized, multicenter, 12-week, ...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,多中心研究,随机对照试验

    doi：10.1016/s0149-2918(98)80112-4

    authors： Walters TR,Maloney S,Slater D,Liss C,Wilson H,Hartenbaum D

    更新日期：1998-11-01 00:00:00

  • Effects of fenofibrate on high-density lipoprotein particle size in patients with hyperlipidemia: a randomized, double-blind, placebo-controlled, multicenter, crossover study.

    abstract：BACKGROUND:Fenofibrate lowers serum total cholesterol and triglyceride levels while it elevates serum high-density lipoprotein cholesterol (HDL-C) level. OBJECTIVE:The aim of this study was to investigate the effects of fenofibrate on the particle size of high-density lipoprotein (HDL). METHODS:Patients with hyperlip...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,多中心研究,随机对照试验

    doi：10.1016/s0149-2918(02)80064-9

    authors： Sasaki J,Yamamoto K,Ageta M

    更新日期：2002-10-01 00:00:00

  • Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability.

    abstract：BACKGROUND:Recently approved for the treatment of schizophrenia, aripiprazole represents the sixth second-generation antipsychotic (SGA) introduced to the US market. Aripiprazole is considered a partial dopaminergic agonist, acting on both postsynaptic dopamine(2) receptors and presynaptic autoreceptors, in addition to...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/s0149-2918(04)90066-5

    authors： DeLeon A,Patel NC,Crismon ML

    更新日期：2004-05-01 00:00:00

  • Idiopathic chronic hiccup: combination therapy with cisapride, omeprazole, and baclofen.

    abstract：:Idiopathic chronic hiccup (ICH) is defined as recurring hiccup attacks that last for longer than an arbitrary time limit (eg, 1 month) and for which no organic cause can be found. In patients with ICH, therapy is largely empiric. For practical purposes, idiopathic hiccup can be assumed to have its origin either in the...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章

    doi：10.1016/s0149-2918(97)80055-0

    authors： Petroianu G,Hein G,Petroianu A,Bergler W,Rüfer R

    更新日期：1997-09-01 00:00:00

  • Human leukocyte interferon in the treatment of rheumatoid arthritis.

    abstract：:Forty patients with symptoms of rheumatoid arthritis were treated with daily injections of 100 micrograms of human leukocyte interferon or saline placebo. Twenty patients received the interferon for nine weeks and were then switched to placebo for nine weeks, and 20 patients were started on placebo and were then switc...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章

    doi：

    authors： Peddinani MV,Savery F,Hang LM

    更新日期：1986-01-01 00:00:00

  • Randomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysis.

    abstract：BACKGROUND:The use of dopamine agonists (DAs) for the treatment of restless legs syndrome (RLS) has been assessed in numerous randomized clinical trials (RCTs). OBJECTIVES:The aims of this study were to assess the reporting quality of published RCTs according to the Consolidated Standards of Reporting Trials (CONSORT)...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,meta分析,评审

    doi：10.1016/j.clinthera.2010.01.028

    authors： Zintzaras E,Kitsios GD,Papathanasiou AA,Konitsiotis S,Miligkos M,Rodopoulou P,Hadjigeorgiou GM

    更新日期：2010-02-01 00:00:00

  • Impact of Penicillin Allergy on Time to First Dose of Antimicrobial Therapy and Clinical Outcomes.

    abstract：PURPOSE:The objective of this study was to evaluate the impact of a listed penicillin allergy on the time to first dose of antibiotic in a Veterans Affairs hospital. Additional clinical outcomes of patients with penicillin allergies were compared with those of patients without a penicillin allergy. METHODS:A retrospec...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2017.09.012

    authors： Conway EL,Lin K,Sellick JA,Kurtzhalts K,Carbo J,Ott MC,Mergenhagen KA

    更新日期：2017-11-01 00:00:00

  • Safety and efficacy of feprazone for long-term treatment of rheumatoid arthritis and osteoarthritis.

    abstract：:Long-term safety and efficacy of feprazone (4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione), an antirheumatic drug that is well tolerated in the gastrointestinal tract, were assessed in a noncontrolled multicenter trial. Administered at a daily dosage of 600 mg for a mean duration of 114.1 days, feprazone was well tolera...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：

    authors： Bianchi G,Cerri B,Grasso S,Carazzi R,Dotti F,Ongari R,Cerrato O,Viara M

    更新日期：1981-01-01 00:00:00

  • New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.

    abstract：BACKGROUND:Reduction in plasma low-density lipoprotein cholesterol (LDL-C) is a fundamental treatment for the prevention of acute coronary syndromes (ACS). Although statin therapy confers significant protection against ACS in both primary and secondary prevention, a considerable residual risk remains after intensive th...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.clinthera.2013.06.019

    authors： Sahebkar A,Watts GF

    更新日期：2013-08-01 00:00:00

  • The impact of budesonide and other inhaled corticosteroid therapies in the management of asthma in children and adults.

    abstract：BACKGROUND:Since the recognition that asthma is characterized by extensive inflammation of the airways, the use of inhaled corticosteroids (ICSs) as controller therapy has become central to successful disease management. As the prevalence of asthma increases worldwide, there is concern about increasing numbers of patie...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/s0149-2918(03)80302-8

    authors： Chapman KR

    更新日期：2003-01-01 00:00:00

  • Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.

    abstract：BACKGROUND:Varenicline was designed to relieve symptoms of nicotine withdrawal, including cigarette craving, and to block the reinforcing effects of continued nicotine use. The cost-effectiveness of varenicline in some countries has not been studied. OBJECTIVE:The aim of this study was to compare the cost-effectivenes...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2012.07.002

    authors： Athanasakis K,Igoumenidis M,Karampli E,Vitsou E,Sykara G,Kyriopoulos J

    更新日期：2012-08-01 00:00:00

  • Effects of dexamethasone in preventing postoperative emetic symptoms after total knee replacement surgery: a prospective, randomized, double-blind, vehicle-controlled trial in adult Japanese patients.

    abstract：BACKGROUND:Postoperative emetic symptoms (nausea, retching, and vomiting) are common following total joint replacement, with an incidence as high as 83% when no prophylactic antiemetic is provided. However, most antiemetics currently used in Japan, such as antihistamines (eg, hydroxyzine), butyrophenones (eg, droperido...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,随机对照试验,收录出版

    doi：10.1016/j.clinthera.2005.05.011

    authors： Fujii Y,Nakayama M

    更新日期：2005-06-01 00:00:00

  • Outcomes of Macrolide Deescalation in Severe Community-acquired Pneumonia.

    abstract：PURPOSE:Current data suggest potential benefits with β-lactam plus macrolide combination therapy for empiric treatment of intensive care unit (ICU) patients with severe community-acquired pneumonia (CAP). However, it is unclear whether deescalation to β-lactam monotherapy in the absence of positive results on diagnosti...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2019.10.005

    authors： Hopkins TM,Juang P,Weaver K,Kollef MH,Betthauser KD

    更新日期：2019-12-01 00:00:00

  • A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.

    abstract：OBJECTIVE:The aim of this study was to test the ability of human insulin 70/30, insulin lispro mixture 75/25 (75% neutral protamine lispro [NPL], 25% insulin lispro), and insulin lispro mixture 50/50 (50% NPL, 50% insulin lispro) to control postprandial glucose (PPG) concentrations in patients with type 2 diabetes mell...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.clinthera.2006.10.017

    authors： Schwartz S,Zagar AJ,Althouse SK,Pinaire JA,Holcombe JH

    更新日期：2006-10-01 00:00:00

  • The prevalence of Chlamydia trachomatis in women with genitourinary symptoms.

    abstract：:Two studies were conducted to determine the prevalence of Chlamydia trachomatis in the urine and cervical exudates of women with genitourinary symptoms. In the first study, 873 women attending the World Health Organization-Sexually Transmitted Disease Center of the Alfred Fournier Institute, in Paris, were examined. I...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：

    authors： Bohbot JM,Catalan F,Sednaoui P,Siboulet A,Siboulet A

    更新日期：1986-01-01 00:00:00

  • Amoxicillin and clavulanic acid combination: clinical and laboratory evaluation in pulmonary infections.

    abstract：:Twenty-four patients with pulmonary infections (7 pneumoniae, 17 exacerbations of chronic bronchitis) were treated with a combination of 250 mg of amoxicillin and 125 mg of clavulanic acid supplemented by 500 mg of amoxicillin every eight hours. All patients showed good clinical, roentgenological, and bacteriological ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：

    authors： Saroglou G,Paniara-Volika O,Sima A,Paraskevopoulou E,Makris G,Hatzimichelakis N,Vassilopoulos N,Kontomichalou P

    更新日期：1982-01-01 00:00:00

  • Stimulation of glucose and amino acid transport and activation of the insulin signaling pathways by insulin lispro in L6 skeletal muscle cells.

    abstract：:The monomeric insulin analogue insulin lispro (Lys B28, Pro B29) is a rapid-acting insulin with a shorter duration of activity than human regular insulin. This compound has the advantage of reducing early postprandial hyperglycemia and the accompanying late hypoglycemia, thereby improving overall blood glucose control...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/s0149-2918(98)80040-4

    authors： Somwar R,Sweeney G,Ramlal T,Klip A

    更新日期：1998-01-01 00:00:00

  • Overview of US Maternal Mortality Policy.

    abstract：:The United States maternal mortality rate has been rising for many years putting the US out of step with peer countries. There are many complex reasons for the rise in maternal deaths and recent data has demonstrated that there is a disproportionate risk for women of color. This article provides an overview of current...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.clinthera.2020.01.015

    authors： Villavicencio JC,McHugh KW,Edmonds BT

    更新日期：2020-03-01 00:00:00

  • The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly.

    abstract：:This study evaluated the efficacy, safety, and most suitable dose of omeprazole in short-term acute treatment (4 weeks) and maintenance treatment (6 months) of patients older than 60 years of age with endoscopically diagnosed gastric ulcer (GU) or duodenal ulcer (DU). This randomized, prospective study included 156 pa...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：

    authors： Pilotto A,Di Mario F,Battaglia G,Vigneri S,Leandro G,Franceschi M,De Boni M,Grasso A,Vianello F,Naccarato R

    更新日期：1994-11-01 00:00:00

  • Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, pros

    abstract：BACKGROUND:High incidences of cardiovascular events coincide with a surge in blood pressure (BP) that occurs in the early morning hours at the time of arousal. Thus, control of BP at this time of day, using oral fixed-dose combinations (FDCs) as required, is important in reducing cardiovascular risk in hypertensive pat...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,meta分析

    doi：10.1016/j.clinthera.2005.11.014

    authors： Lacourcière Y,Neutel JM,Schumacher H

    更新日期：2005-11-01 00:00:00

  • Importance of observational studies in clinical practice.

    abstract：BACKGROUND:In this era of evidence-based medicine, clinicians require a comprehensive range of well-designed studies to support prescribing decisions and patient management. In recent years, data from observational studies have become an increasingly important source of evidence because of improvements in observational...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.clinthera.2007.07.004

    authors： Ligthelm RJ,Borzì V,Gumprecht J,Kawamori R,Wenying Y,Valensi P

    更新日期：2007-06-01 00:00:00

  • A weekly schedule of low-dose doxorubicin in treatment of advanced breast cancer.

    abstract：:A phase II study of weekly low-dose doxorubicin (6 to 12 mg/m2) showed it to be an effective, well-tolerated therapy in advanced breast cancer. Although most of the 34 patients studied had been clinically resistant to previous endocrine measures and/or other kinds of chemotherapy, had a median score of 60 on Karnofsky...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：

    authors： Mattsson W,Borgström S,Landberg T

    更新日期：1982-01-01 00:00:00

  • Activation of kinin-prekallikrein system after infusion of factor VIII concentrates in hemophilic patients.

    abstract：:Possible changes in the kinin-prekallikrein system after infusion of factor VIII concentrate were studied in seven patients with severe hemophilia. The functional and immunological activities of factors XI and XII, prekallikrein, high molecular weight kininogen, and C-1-esterase inhibitor were measured before and at 0...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：

    authors： Alegre A,Alberca I,Vicente V

    更新日期：1986-01-01 00:00:00

  • Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: a phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study.

    abstract：BACKGROUND:Risedronate 5 mg/d is approved by the US Food and Drug Administration for the treatment and prevention of postmenopausal osteoporosis. Once-monthly dosing options might increase treatment compliance and persistence. OBJECTIVE:The aim of this study was to compare the tolerability and efficacy of 3 once-month...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1016/j.clinthera.2009.02.012

    authors： Ste-Marie LG,Brown JP,Beary JF,Matzkin E,Darbie LM,Burgio DE,Racewicz AJ

    更新日期：2009-02-01 00:00:00

  • Insulin glargine.

    abstract：BACKGROUND:In diabetes mellitus, the clinical goal of intensive glycemic control (lowering blood glucose concentrations to normal or near-normal levels) has been hindered by the lack of insulin regimens that duplicate the basal-bolus secretion of insulin by the healthy pancreas. In particular, intensive therapy has bee...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/s0149-2918(01)80148-x

    authors： Campbell RK,White JR,Levien T,Baker D

    更新日期：2001-12-01 00:00:00

  • Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the United States.

    abstract：BACKGROUND:Prophylaxis with granulocyte colony-stimulating factor reduces the risk for febrile neutropenia (FN) in patients receiving myelosuppressive chemotherapy. OBJECTIVE:We estimated the incremental cost-effectiveness of primary prophylaxis (starting in cycle 1 of chemotherapy) with pegfilgrastim versus filgrasti...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2009.05.003

    authors： Lyman GH,Lalla A,Barron RL,Dubois RW

    更新日期：2009-05-01 00:00:00

  • Effects of comorbidity on health-related quality-of-life scores: an analysis of clinical trial data.

    abstract：:Coexisting diseases may have unforeseen yet clinically significant effects on patients' well-being. Both generic and disease-specific measures are frequently used to assess health-related quality of life (QOL). The present study assessed the effects of comorbidity on the results of QOL measures through an analysis of ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/S0149-2918(00)88295-8

    authors： Xuan J,Kirchdoerfer LJ,Boyer JG,Norwood GJ

    更新日期：1999-02-01 00:00:00

  • Cost-effectiveness of everolimus for second-line treatment of metastatic renal cell carcinoma in Serbia.

    abstract：BACKGROUND:New targeted therapeutics for metastatic renal cell carcinoma (mRCC) enable an increment in progression-free survival (PFS) ranging from 2 to 6 months. Compared with best supportive care, everolimus demonstrated an additional PFS of 3 months in patients with mRCC whose disease had progressed on sunitinib and...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2013.10.004

    authors： Mihajlović J,Pechlivanoglou P,Sabo A,Tomić Z,Postma MJ

    更新日期：2013-12-01 00:00:00